Delivery Order SPE2DB20D3103-SPE2DB25FM8G8
Award Date
2/24/25
Potential Completion Date
3/17/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 delivery order contract is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has a ceiling value of $3,425.95 and runs through March 20, 2025. The contract is a firm fixed-price delivery order and does not have any set-aside requirements. AmerisourceBergen Drug Corp...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,311.50 firm fixed-price delivery order is for ESBRIET 267 MG CAPSULE 270S, with a completion date of December 18, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order (SPE2DB20D2001|SPE2DB25FPLUQ) with a firm fixed price, and the ultimate completion date is February 3, 2025. The contract does not have a set-aside designation, indicating open competition. The contract provides for the delivery of ESBRIET 267 MG TABLET 270S, a pharmaceutical product, to support...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,425.95 firm fixed-price delivery order contract covers the supply of ESBRIET 267 MG TABLET 270S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025 and was awarded on December 31, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $3,425.95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ESBRIET 267 MG CAPSULE 270S, a medical product, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB24D1007|SPE2DB25FBZUB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,425.95 firm fixed-price delivery order is for the supply of ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp's Corporate Office Division. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense's (DoD) military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.90 firm fixed-price delivery order is for the supply of ESBRIET 801 MG TABLET 90S, a pharmaceutical product, with a period of performance through January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,425.95 delivery order is for ESBRIET 267 MG CAPSULE 270S, a pharmaceutical product, with a firm fixed price and an ultimate completion date of December 24, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...